Bioprocess Hub
Join free
🌐 Live from the web

Market news

The breakthroughs, deals and approvals moving the bio-economy β€” tracked across every sector, updated daily.

Updated 9/17/2026

Vyriad Highlights G‑Link Platform for Flexible Cell and Gene Therapy Targeting

Read at TipRanks β†’

Novartis and BMS Pause Autoimmune CAR T Trials Over Safety Concerns

Read at The Medicine Maker β†’

Glidepath Health Launches to Bring Operational Certainty to Cell and Gene Therapy Delivery

Read at Business Wire β†’

Axiom Biosciences Expands Manufacturing and Clinical Development Capabilities Through Partnership with GeneFab

Read at GlobeNewswire β†’

Cellectis scraps CAR-T pipeline in gene editing pivot

Read at European Biotechnology Magazine β†’

Circio announces that it has completed a capital raise of approx. NOK 200 million towards its in vivo CAR-T program

Read at Finansavisen β†’